Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The PRS-343 Phase 1 study record for HER2-positive advanced or metastatic solid tumors is displayed, with trial details, participant criteria, study locations, and record dates. The record indicates that the study is completed and is no longer recruiting participants.
    Difference
    50%
    Check dated 2026-11-08T13:19:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision indicator was updated from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:58:37.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related terminology updates, including the use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:32:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:03:28.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, indicating access to the study record is blocked. The added HTML content confirms an access-denied state rather than the study details.
    Difference
    0.5%
    Check dated 2026-09-27T19:44:28.000Z thumbnail image

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.